Effect of statin therapy on renal and lipid outcomes in CKM syndrome stage 2: a meta-analysis of randomized controlled trials
Abstract Cardiovascular–kidney–metabolic (CKM) syndrome is a recently defined multisystem disorder integrating metabolic, renal, and cardiovascular dysfunction. CKM syndrome stage 2 represents an early, potentially reversible phase that offers a critical window for intervention. This meta-analysis e...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2025-12-01
|
| シリーズ: | BMC Nephrology |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s12882-025-04645-8 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
